Earnings Call · Q2 FY2024·2024-08-11

Q2 24EPS +18.75%·Rev n/aQ1 24EPS +12.50%·Rev n/aQ4 23EPS 0.00%·Rev n/aQ3 23EPS +7.69%·Rev n/a⚠ consensus missing

DiaMedica Therapeutics Inc. DMAC

Rick Pauls — Chief Executive Officer

Lorianne Masuoka — Chief Medical Officer

Scott Kellen — Chief Financial Officer

+3.1%1d on move date+0.8% vs SPY3d+8.6%5d+7.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DMAC calls or request research access.

More DMAC calls Browse calls Request research access